๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2024-08-19

LTFU Study of Subjects Who Received GRNOPC1 (NCT05919563)

Long Term Follow-up of Subjects Who Received GRNOPC1

๐Ÿ”ต Active, Not Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: Lineage Cell Therapeutics, Inc.

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This is a LTFU study for thoracic SCI subjects that were administered GRNOPC1 cells in the main study CP35A007.

Who can join: Review the eligibility criteria below.

Location: Stanford University โ€” Palo Alto, California

Age range: 18 Years to 65 Years

๐Ÿงช Interventions in This Study

  • Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (3 Sites)

  • Stanford University โ€” Palo Alto, California
  • Shepherd Center โ€” Atlanta, Georgia
  • Northwestern Medical Group โ€” Evanston, Illinois

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—